Rsv vaccine, pref a-pref b, recombinant Disease Interactions
There are 2 disease interactions with rsv vaccine, pref a-pref b, recombinant.
RSV vaccine (applies to rsv vaccine, pref a-pref b, recombinant) immunodeficiency
Moderate Potential Hazard, Moderate plausibility.
Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to the RSV vaccine.
RSV vaccine (applies to rsv vaccine, pref a-pref b, recombinant) syncope
Moderate Potential Hazard, Moderate plausibility.
Syncope may occur in association with administration of injectable vaccines, including the RSV vaccine. Procedures should be in place to avoid injury from fainting, especially for patients who have previously fainted in association with an injection.
Switch to professional interaction data
Rsv vaccine, pref a-pref b, recombinant drug interactions
There are 299 drug interactions with rsv vaccine, pref a-pref b, recombinant.
More about rsv vaccine, pref a-pref b, recombinant
- rsv vaccine, pref a-pref b, recombinant consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.